An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoring
The predictive score provides clinicians with an effective tool to support individualised linezolid therapy and guide TDM implementation, reducing the risk of toxicity or treatment failure.
Authors
- Jaime Barceló‐Vidal (ORCID: https://orcid.org/0000-0002-4609-0465)
- Daniel Fresán
- C de Cáceres Velasco
- Sònia Luque (ORCID: https://orcid.org/0000-0002-3215-320X)
- Rosana Acquaroni Muñoz
- Adela Benítez-Cano (ORCID: https://orcid.org/0000-0003-4794-5936)
- Luisa Sorlí (ORCID: https://orcid.org/0000-0001-9562-514X)
- Isaac Subirana (ORCID: https://orcid.org/0000-0003-1676-0197)
- Antoni Ferrer (ORCID: https://orcid.org/0000-0001-6317-7039)
- Ana Rodrigo-Moreno
Institutions
- Generalitat de Catalunya (ES)
- Royal Brisbane and Women's Hospital (AU)
- Instituto de Salud Carlos III (ES)
- Hospital Del Mar (ES)
- Parc de Salut (ES)
- European Society of Clinical Microbiology and Infectious Diseases (CH)
- Institut Català de la Salut (ES)
- Hospital del Mar Research Institute (ES)
Publication Details
- Journal
- International Journal of Antimicrobial Agents
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.ijantimicag.2025.107661
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00